Skip to Main Content

Free Sessions on Substance Use Disorders

Free & Online!


FREE Training for Nurses = 11 Courses with NCPD Contact Hours

The 11 sessions provide knowledge related to care for persons with a substance use disorder diagnosis, available free to everyone until September 29, 2024!

Funding for this initiative was made possible (in part) by grant no.1H79TI0855888-02 from SAMHSA in conjunction with the Opioid Response Network (ORN). The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Please refer to each session description for instructions on completing this free education to earn contact hours.

The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Just Announced! New Free Sessions

Computer-Based Learning for Opioid Use Disorder (CLOUD)

Contact Hours: 0.5
This presentation introduces the implementation of an evidence-based intervention that can be accessed over the web by patients with opioid use disorder (OUD) in a community integrated-care setting

Helping Older Adults with Opioid Use Disorders Stay Healthy and in Recovery

Contact Hours: 0.5
This presentation will describe the demographics and the most common co-occurring medical, psychiatric, and substance use disorders in older adults with opioid use disorders in FQHC clinics in lower

Addressing Bias and Stigma in the Language We Use with Persons with Opioid Use Disorder

Contact Hours: 0.75
This presentation will describe difficulties with access to care of opioid use disorders (OUDs), the stigmatizing languages that presents barriers to effective care, and suggest alternative language to be used

Closing the Opioid Treatment Gap through Advance Practice Nursing Activation

Contact Hours: 0.25
We present curricular design and measurable objectives for a course that prepares APRN students to deliver medications for opioid use disorder (MOUD), especially for under-served populations.

Meet OWEP! Opioid Substance Use Disorders Recovery/Systems-Oriented Practice in Integrated Health Care/Telehealth

Contact Hours: 1.5
This exciting presentation informs RN/APN of OID/SUD updates to care setting options adopted from a Graduate Nursing IOD/SUD HRSA funded recovery-based program intended to empower APNs

Increasing Access to Buprenorphine for Individuals with Opioid Use Disorder: DATA Waiver Training Overview and Nursing Curricula Recommendations

Contact Hours: 0.75
This presentation will discuss increasing access to treatment for individuals with OUD through the use of the DATA waiver/exemption. Suggestions for DATA waiver training inclusion in graduate nursing school

Retrospective Study on the Effects Of Extended-Release Naltrexone (XR-NTX) Injection Among Justice-Involved Adults Misusing Opioids Released from Correctional Facilities In Louisiana

Contact Hours: 0.5
This presentation highlights the results of the first retrospective study on extended-released naltrexone offered by the Medication-for Opioid Use Disorder (MAT) Program by the Department of Corrections in

Goodbye X-Waiver: Good News for PMHNPs and for the Treatment of People with Opioid Use Disorder

Contact Hours: 0.75
This interactive presentation discusses the 2023 legislation eliminating the DEA X-Waiver buprenorphine prescription requirement and the implications for clinical practice.

Updated Buprenorphine Prescribing Training Requirements for APRNs

Contact Hours: 0.5
This presentation examines the new training requirements for APRNs who wish to prescribe buprenorphine as outlined by the Consolidated Appropriations Act, and explores the Office of National Drug Control Policy’

Evaluating Cholesterol Biomarker, Treatment, and Socio-Demographic Factors as Indicators of Opioid Use Disorder Treatment Retention

Contact Hours: 0.75
This interactive presentation introduces supporting evidence on clinical use of cholesterol biomarker and integrated health service provision in opioid treatment program to promote retention of minority patients.

Buprenorphine Induction in the Era of Fentanyl: Avoiding Precipitated Withdrawal Symptoms

Contact Hours: 0.75
Concepts related to buprenorphine microdosing for patients using fentanyl and the risk for precipitated withdrawal. The participant will leave with the knowledge and skills required to implement high-quality, evidence-